Company / Net Income
Catalyst Pharmaceuticals Partners, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$214.3M
FY2025
5-year range
$39.5M / $214.3M
FY2021-FY2025
Trend
+30.8%
vs FY2024
Sector context
#33 of 216
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s net income of $214M is higher than 85% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$34M in FY2018 to $214M in FY2025.
Based on SEC 10-K filings.
$214M in FY2025 with a 5-year CAGR of +23.4%. Top quartile in the Health Care sector.
Improved from $71M to $214M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +37.1%
- 5-Year CAGR
- +23.4%
- 10-Year CAGR
- -
Sector benchmark
-52.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.4%, indicating consistent growth.
- In FY2025, net income increased 30.8% year-over-year.
- Ranks #33 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $214.3M | +30.8% |
| FY2024 | $163.9M | +129.5% |
| FY2023 | $71.4M | -14.0% |
| FY2022 | $83.1M | +110.4% |
| FY2021 | $39.5M | -47.3% |
| FY2020 | $75.0M | +135.2% |
| FY2019 | $31.9M | +193.7% |
| FY2018 | -$34.0M | -68.1% |
| FY2017 | -$20.2M | -12.0% |
| FY2016 | -$18.1M | +10.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026